Follow-up time in clinical trials with a time-to-event endpoint: Redefining the question(s)

Aug 22, 2022
00:00

MIRROS: Planning a Phase 3 Trial with Time-to-event Endpoint, a Cure Proportion, and a Futility Interim Analysis using Response

Aug 6, 2022
00:00

Answering Old Questions with New Tools: Application of the ICH E9 Addendum in Oncology (virtual event)

Dec 16, 2021
00:00

MIRROS: Planning a Phase 3 Trial with Time-to-event Endpoint, a Cure Proportion, and a Futility Interim Analysis using Response

Sep 8, 2021
00:00

Use of multistate models to jointly model progression-free and overall survival and improve decision-making in clinical trials

Nov 14, 2019
14:00

Implications of the ICH E9 estimand addendum on how we develop, run, and analyze clinical trials

Oct 16, 2019
11:25

Before going BIG - seize opportunities for small data: use of multistate models to improve decision-making and effect quantification in clinical trials

Sep 10, 2019
15:10

Multistate models to improve decision-making and effect quantification in clinical trials

Jun 27, 2019
00:00

Bayesian Predictive Power: Theory, challenges in implementation, and perspectives

May 23, 2019
00:00

Univariate log-concave density estimation and more efficient treatment effect estimation in pre-specified subgroups displayed in forest plots for time-to-event outcomes

Nov 22, 2018
00:00

MIRROS: Planning a Phase 3 trial with time-to-event endpoint, a cure proportion, and a futility interim analysis using response

Oct 23, 2018
00:00

Randomization and External Controls - When to Use What in a Drug Development Landscape

Oct 18, 2018
00:00

More efficient treatment effect estimation in pre-specified subgroups displayed in forest plots for time-to-event outcomes

Oct 4, 2018
00:00

Treatment effect measures for time-to-event endpoints - estimands, analysis strategies, and beyond

Nov 24, 2017
00:00

Bayesian Predictive Power: update after a blinded interim analysis and choice of update after a blinded interim analysis and choice of prior

Dec 12, 2016
00:00

Bayesian Predictive Power: update after a blinded interim analysis and choice of prior

Nov 10, 2016
00:00

Bayesian Predictive Power: Choice of Prior and some Recommendations for its Use as Probability of Success in Drug Development

May 24, 2016
00:00

A Weibull Regression Model for a Time-to-Event Endpoint with an Interval-Censored Covariate and its Application in Assessing Prentice's Criteria for Surrogacy

Nov 20, 2015
00:00

Comparison of clinical development plans for a confirmatory trial with subpopulation selection

Jun 18, 2015
00:00

Evaluation of possible designs for a three-arm clinical trial: Comparing a closed-testing design to potential alternatives

Jun 16, 2015
00:00

© 2019 · Powered by the Academic theme for Hugo.